EPO and major depressive disorder: Nevertheless, the beneficial effects of EPO on cognition and hippocampal volume have been observed across several neuropsychiatric diseases including MDD, BD40 and schizophrenia67, suggesting that EPO modulates common signalling pathways involved in neuroplasticity and cognition across these disorders.